Log in to save to my catalogue

Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an...

Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2314007390

Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir

About this item

Full title

Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Infection, 2020-04, Vol.48 (2), p.213-221

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
Weight gain after initiation of combination antiretroviral therapy (cART) is a possible side effect of all antiretroviral regimens, but it seems to be more evident in association with integrase strand transfer inhibitors (INSTIs). So, we aimed to evaluate weight change associated with an initial cART including one INSTI or darunavir–r...

Alternative Titles

Full title

Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2314007390

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2314007390

Other Identifiers

ISSN

0300-8126,1439-0973

E-ISSN

1439-0973

DOI

10.1007/s15010-019-01376-5

How to access this item